Inventory / revenue moved 216 bp higher
Inventory / revenue changed +216 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +216 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +978 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -13.9% from the comparable as-filed period.
Noncurrent long-term debt changed +23.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -3.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / assets changed +557 basis points from the comparable as-filed period.
Cash / debt changed -3625 basis points from the comparable as-filed period.
Operating cash flow changed -8.1% from the comparable as-filed period.
Debt / revenue changed +4663 basis points from the comparable as-filed period.
Stock-based compensation changed +16.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +7.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -6.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +12.7% from the comparable as-filed period.
SBC / revenue changed +11 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed +56 basis points from the comparable as-filed period.
Free-cash-flow margin changed -139 basis points from the comparable as-filed period.
Inventory changed +1.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross profit changed +2.7% from the comparable as-filed period.
Selling, general & administrative changed -3.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +25 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -83 basis points from the comparable as-filed period.
Shares outstanding changed -4.1% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Debt / assets changed +531 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +18.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed -15.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash / debt changed -1494 basis points from the comparable as-filed period.
Debt / revenue changed +3885 basis points from the comparable as-filed period.
Revenue changed +1.5% from the comparable as-filed period.
Capital expenditure changed -9.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed -4.9% from the comparable as-filed period.
Free-cash-flow proxy changed -2.9% from the comparable as-filed period.
Capex / revenue changed -45 basis points from the comparable as-filed period.
Gross profit changed +8.0% from the comparable as-filed period.
Cash & equivalents changed +9.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +1.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -2.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -5 basis points from the comparable as-filed period.
Stock-based compensation changed -7.7% from the comparable as-filed period.
Trade receivables changed +2.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Receivables / revenue changed +43 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -84 basis points from the comparable as-filed period.
R&D / revenue changed +1 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -39 basis points from the comparable as-filed period.
Current assets changed +0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.